Original perspective


Link to Viscofan-bioengineering

Despite the field of corporate social responsibility action being very wide, given that it encompasses all the interest groups and can appear in a multitude of projects, the company understands that it can create sustainable value in some specific spheres that are more in keeping with its corporate activity. 

This is the case of bioengineering, which is the result of the knowledge the company has of the raw materials with which it works, in this case, collagen. In this project the underlying conviction is that the company is responsible for returning its knowledge to improve the well-being and health of individuals

Today, the Viscofan Bioengineering project, established in 2008, continues to make advances. It combines biosciences with engineering to provide innovative bio-products such as new solutions to cellular biology, tissue engineering, and regenerative medicine. This division within the Viscofan Group is the result of the company’s know-how on collagen in the field of food, and, when transferred to another sphere - biomedicine - the outcome is an innovative knowledge of the possibilities of collagen film as a cellular regenerator in cardiovascular, urological and oral tissues. 

Collagen is an animal protein that is extracted from the dermis and which is hugely versatile in terms of manufacture and use, as well as holding a high degree of bio-compatibility, transforming it into a very suitable bio-polymer for customized solutions in the field of biomedical research and development.

Alongside this, these advances have led the Viscofan Group to invest 2 million euros in the installation of a white room in Weinheim (Germany), an annex to the collagen production centre and with the capacity of undertaking clinical studies.

The Viscofan Bioengineering division focuses on research in the field of bioengineering, undertaken in collaboration with other research centres. We work with various prestigious international technological partners such as the University of Tübingen (Germany), the Centre for Applied Medical Research (CIMA) from the University of Navarre (Spain), the University of South Carolina (USA), and the Research Institute of Leather and Plastic Sheeting (FILK) in Freiberg (Germany), and with a group of financial partners among which, in particular, are the CDTI and the German Ministry for Education and Research.

Viscofan Bioengineering  has a specific communicationchannel on

Usamos cookiesPolitica de cookies. Accept